Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Medical Data Vision, Returning to Profitability This Year, Dividend Raised by 2.5 yen
3902 Medical Data Vision Co.,Ltd. 【J-GAAP】
Earnings ReportMedical Data Vision Co.,Ltd. <3902> [TSE Prime] announced its financial results after the market closed on February 10th (15:30). The consolidated net income/loss for the fiscal year ending December 2024 turned into a loss of 0.79 billion yen (compared to a profit of 0.97 billion yen in the previous period), falling below the forecast of a 0.18 billion yen, and tuning into a loss. In the fiscal year ending December 2025, the profit is expected to surge, reaching 1.65 billion yenExpected to reach record high profits for the first time in four years.
At the same time, the company has decided to increase the dividend this fiscal year to 9 yen, an increase of 2.5 yen from the previous fiscal year.
In the most recent three-month period, from October to December (4Q), the consolidated net income/loss turned to a loss of 0.47 billion yen (compared to a profit of 0.32 billion yen in the same period last year). The operating profit margin sharply declined from 34.1% in the same period last year to 8.0%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec, 2022 | 6,104 | 1,758 | 1,750 | 870 | 22.8 | 6 | Feb 13, 2023 | J-GAAP |
Dec, 2023 | 6,419 | 1,770 | 1,700 | 979 | 25.6 | 6.50 | Feb 13, 2024 | J-GAAP |
Dec, 2024 | 5,906 | 3 | -509 | -791 | -20.7 | 6.50 | Feb 10, 2025 | J-GAAP |
YoY | -8.0% | -99.8% | - | - | - |
Full Year Results vs. Previous Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec, 2024 Guidance | 6,600 | 510 | 390 | 180 | 4.8 | 6.50 | Nov 11, 2024 | J-GAAP |
Dec, 2024 Results | 5,906 | 3 | -509 | -791 | -20.7 | 6.50 | Feb 10, 2025 | J-GAAP |
Revision Rate | -10.5% | -99.4% | - | - | - |
Current Period Guidance
H1 Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Jan - Jun, 2024 | 2,780 | 26 | -32 | -86 | -2.3 | 0 | Aug 8, 2024 | J-GAAP |
Jan - Jun, 2025 Guidance | ー | ー | ー | ー | - | 0 | Feb 10, 2025 | J-GAAP |
YoY | - | - | - | - | - |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec, 2023 | 6,419 | 1,770 | 1,700 | 979 | 25.6 | 6.50 | Feb 13, 2024 | J-GAAP |
Dec, 2024 | 5,906 | 3 | -509 | -791 | -20.7 | 6.50 | Feb 10, 2025 | J-GAAP |
Dec, 2025 Guidance | 9,000 | 2,600 | 2,500 | 1,650 | 43.6 | 9 | Feb 10, 2025 | J-GAAP |
YoY | +52.4% | +86,566.7% | - | - | - |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Dec, 2023 | 1,932 | 659 | 637 | 320 | 8.4 | 34.1 | Feb 13, 2024 | J-GAAP |
Jan - Mar, 2024 | 1,388 | 53 | 22 | -15 | -0.4 | 3.8 | May 13, 2024 | J-GAAP |
Apr - Jun, 2024 | 1,392 | -27 | -54 | -71 | -1.9 | -1.9 | Aug 8, 2024 | J-GAAP |
Jul - Sep, 2024 | 1,345 | -166 | -197 | -228 | -6.0 | -12.3 | Nov 11, 2024 | J-GAAP |
Oct - Dec, 2024 | 1,781 | 143 | -280 | -477 | -12.5 | 8.0 | Feb 10, 2025 | J-GAAP |
YoY | -7.8% | -78.3% | - | - | - |
Related Articles
Keio, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 25%
MATSUYA FOODS, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 4%, Exceeds Full-Year Plan
D.Western Therapeutics Institute, The Current Fiscal Year's Net Income to Narrow
ASAHI RUBBER, Apr-Dec (Cumulative 3Q) Ordinary Profit Turns to Loss, Oct-Dec Ordinary Profit Decreases by 48%
EBARA JITSUGYO, 5% Increase in Ordinary Profit, Update Record High for Third Consecutive Term, Dividend Raised by 25 yen
TAKI CHEMICAL, 41% Decrease in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 5 yen
NOHMI BOSAI, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 2.1 times, Oct-Dec Ordinary Profit Increases by 2.0 times
DAIICHI KOUTSU SANGYO, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 48%, Oct-Dec Ordinary Profit Decreases by 65%
KYOWA ELECTRONIC INSTRUMENTS, 1% Decrease in Ordinary Profit for The Current Fiscal Year, Increased Previous Year's Dividend by 3.5 yen, Plan to Continue the 20 yen Policy This Fiscal Year as Well
HARADA INDUSTRY, The Current Fiscal Year Ordinary Profit Revised Upward to an Unexpected 74% Increase